Take Up Global Biologics Market Opportunities with Clear Industry Data – Includes Biologics Market Trends
The Business Research Company’s report goes into great detail on the biologics market size and growth, biologics market regional analysis, biologics market competitive landscape, and other critical information needed to excel in the biologics industry.
Major players in the biologics market include Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc.
TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.
The biologics market is expected to grow from $253.41 billion in 2020 to $420.55 billion in 2025 at a rate of 10.7%. The market is then expected to grow at a CAGR of 9.6% from 2025 and reach $664.74 billion in 2030.
North America was the largest region in the global biologics market, accounting for 53.2% of the total in 2021.
The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The biologics market comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.
Increasing funding from public and private organizations for the development of vaccines against COVID-19 is expected to drive the market in the forecast period.
Companies in the biologics market are generating high profit margins due to high prices of biologics and their effectiveness.
TBRC’s Global Biologics Market Report Is Segmented:
By Type: Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Monoclonal Antibodies (MAbS), Anti-Cancer MAbs, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MAbs, Cardiovascular And Cerebrovascular MAbs, Others – Monoclonal Antibodies (MAbs), Vaccines, Anti-Infective Vaccines, Autoimmunity Vaccines, Others-Vaccines
By Route Of Administration: Oral, Others (IV and IP)
By Drug Classification: Branded Drugs, Generic Drugs,
By Mode Of Purchase: Prescription Drugs, Over-The-Counter (OTC) Drugs
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
The Biologics Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the biologics market globally and regionally, analyzes and forecasts market size, share, biologics market players, biologics market segments, leading competitor revenues, profiles and market shares.
Here Is A List Of Similar Reports From The Business Research Company:
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: